| A New Look at Cardiac Exercise Testing. (Curfman GD, Hillis LD. N Engl J Med 2003; 348:775-776) |
| A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes. . (Gluckman TJ, Sachdev M, Schulman SP et al. JAMA 2005; 293: 349-357) |
| Drug-Eluting Stents for the Management of Restenosis: A Critical Appraisal of the Evidence. . (Tung R, Kaul S, Diamond GA et al . Ann Intern Med. 2006;144:913-919) |
| Invasive vs Conservative Management of Acute Coronary Syndromes: Do the Data Support the Guidelines?. (Cohen DJ. JAMA 2002; 288: 1905-1907) |
| Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials. (Mehta SR, Canon CP, Fox KAA et al. JAMA 2005; 293: 2908-2917) |
| The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. (RALES investigators. N Engl J Med 1999; 341:709-717) |
| A Classification of Unstable Angina Revisited. (Hamm CW, Braunwald E. Circulation. 2000 Jul 4;102(1):118-22.) |
| A Comparison of Rate Control and Rhythm Control in Patients with Atrial fibrillation. . (AFFIRM Investigators. N Engl J Med 2002; 347:1825-1833) |
| ACC/AHA Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. ( AHA ACC 2007 UA-STEMI.Card.Final) |
| Acute Pericarditis: Diagnostic Cues and Common Electrocardiographic Manifestations. (Ariyarajah, V; Spodick DH. Cardiology in Review. 15(1):24-30, January/February 2007.) |
| Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded. (Allen J. and Gibson CM. Ann Intern Med. 2005;142:786-791) |
| Angina With "Normal" Coronary Arteries: A Changing Philosophy. (Bugiardini R and Merz CNB. JAMA 2005; 293: 477-484) |
| Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes. (Schulman SP . JAMA 2004; 292: 1875-1882) |
| Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure. (Rathore SS, Curtis JP, Wang Y et al. JAMA 2003; 289: 871-878.) |
| Beta-blockers in Heart Failure: Clinical Applications.. (Farrell MH, Foody JAM, Krumholz HM et al. JAMA 2002; 287: 890-897) |
| Biventricular Pacing. (Jarcho JA. New Engl J med 2006;355:288-94) |
| Blocker Therapy in Heart Failure: Scientific Review. (Foody JAM, Farrell MH, Krumholz HM et al. JAMA 2002; 287: 883-889) |
| Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity.. (J. Finsterer, C. Stöllberger, W. Krugluger. The Netherlands journal of medicine 2007;65(8):289-95.) |
| Cardiac troponins and renal function in nondialysis patients with chronic kidney disease.. (Abbas NA, et al. Clin Chem 2005;51:2059-66.) |
| Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure. . (Bristow MR. N Engl J Med 2004; 350:2140-2150) |
| Clinical benefits of low serum digoxin concentrations in heart failure. (Adams KF, Gheorghiade M, Uretskyal BF et al. J. Am. Coll. Cardiol. 2002;39;946-953) |
| Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. (Bhatt DL, Fox KAA, Werner Hacke W, et al. NEJM 2006;354:1706-17) |
| Contemporary Definitions and Classification of the Cardiomyopathies.. (Maron BJ et al (AHA) Circulation 2006; 113: 1807 - 1816.) |
| Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction. (TACTICS-TIMI 18 Investigators. JAMA 2002; 288: 1851-1858) |
| Current Concepts: ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction. (Wang K, Asinger RW, Marriott HJL. N Engl J Med 2003; 349:2128-2135) |
| Diastolic Heart Failure. (Aurigemma GP, Gaasch WH. Diastolic Heart Failure. N Engl J Med 2004; 351:1097-1105) |
| Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure? . (Wang CS et al. JAMA 2005; 294: 1944-1956) |
| Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. . (CURE Investigators. N Engl J Med 2001; 345:494-502) |
| Evaluation and Management of the Patient with Pulmonary artery hypertension. (Rubin LJ, MD, and Badesch DB. Ann Int Med, Aug 2005;144: 282-292) |
| Evaluation of Primary Care Patients with Chronic Stable Angina: Guidelines from the ACP. (Snow V, Barry P, Fihn SD, Gibbons RJ, et al. Ann Intern Med 2004;141:57-64) |
| How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction Sanderson3by the Heart Failure and Echocardiography Associations of the ESC. (Paulus WJ, Tschöpe C, Sanderson JE. Eur Heart J (2007) 28(20):2539-25 ) |
| Implantable Cardioverter–Defibrillators. . (DiMarco J. P. N Engl J Med 2003; 349:1836-1847) |
| Is digoxin a drug of the past? . (Pervaiz MH, Dickonson MG and Yamani M. Cleveland clinic journal of med 2006;73:821-834) |
| Jugular Venous Pulse: An Appraisal . (Garg N, Garg N. Journal, Indian Academy of Clinical Medicine Vol. 1, No. 3 Oct.-Dec. 2000) |
| Neurocardiogenic Syncope. (Grubb BP. N Engl J Med 2005; 352:1004-1010) |
| Newly Diagnosed Atrial Fibrillation. (Page RL. N Engl J Med 2004; 351:2408-2416) |
| Noninvasive Tests in Patients with Stable Coronary Artery Disease . (Lee TH., Boucher CA. N Engl J Med 2001; 344:1840-1845) |
| Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease. (Tran H et al. JAMA 2004; 292: 1867-1874) |
| Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials. (Yan AT, Yan RT, Liu PP. Ann Int Med, Jan 2005; 142: 132 - 145) |
| Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with heart failure. (Drazner MH, Rame JE, Stevenson LW et al. N. Engl. J. Med. 2001; 345:574-581) |
| Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. (DEFINITE investigators. N Engl J Med 2004;350:2151-8) |
| Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study. (Juurlink DN. N Engl J Med 2004; 351:543-551) |
| Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy. (AHA. Schoolwerth AC, Domenic A, Sica DA, Ballermann BJ et al. Circulation. 2001;104:1985-91) |
| Risk factors and angiographic coronary artery disease: a report from the coronary artery surgery study (CASS). (Vlietstra RE et al. Circulation. 1980;62:254-261) |
| Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure. (Fonarow GC, Adams KF, Abraham WT et al JAMA 2005; 293: 572-580) |
| Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. (Ridker PM et al. n engl j med 359;21:2195-2207) |
| Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin. (Gage BF et al. Circulation 2004; 110: 2287 - 2292) |
| Sudden Death Due to Cardiac Arrhythmias.. (Huikuri HV. N Engl J Med 2001; 345:1473-1482) |
| Supraventricular tachycardias. (Chauhan VS et al. The Medical clincs of North America March 2001 (Vol. 85, Issue 2) pp 193 -223) |
| Syncope Resulting from Autonomic Insufficiency Syndromes Associated with Orthostatic Intolerance . (Grubb BP and Kosinski DJ. The Medical Clinics of North America March 2001 (Vol. 85, Issue 2) pp 457 -472) |
| Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction. (Ezekowitz JA, Rowe BH, Dryden DM et al: Ann Int med, August 2007;147: 251-262) |
| Systolic and Diastolic Heart Failure in the Community. (Bursi F, Weston SA, Redfieldet MM al. JAMA 2006; 296: 2209 - 2216) |
| The 2006 American Heart Association Classification of Cardiomyopathies Is Not the Gold Standard. (Elliott P. Circ Heart Fail. 2008;1:77– 80) |
| The 2006 American Heart Association Classification of Cardiomyopathies Is the Gold Standard. (Maron JM. Circ Heart Fail 2008;1;72-76) |
| The differential diagnosis of acute pericarditis from the normal variant: new electrocardiographic criteria. . (Ginzton LE, Laks MM. Circulation 1982;65: 1004-9.) |
| The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. (CARE-HF study investigators. N Engl J Med 2005; 352:1539-1549) |
| The effect of digoxin on mortality and morbidity in patients with heart failure . (Digitalis Investigation Group. N Engl J Med. 1997;336:525–533) |
| The Role of Cardiac Risk Factor Burden in Diagnosing Acute Coronary Syndromes in the Emergency Department Setting. (Han JH, Lindsell CJ, Storrow AB et al. Ann Emerg Med. 2007 Feb;49(2):145-152) |
| The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making. (Antman EA, Cohen M, Bernink PJLM et al. JAMA 2000; 284: 835-842) |
| The Venous Pressure and Venous Pulse in the Clinical Examination of the Heart. I. The Venous Pressure. (Cronin RFP. Can Med Assoc J. 1958 March 1; 78(5): 337–342.) |
| The Venous Pressure and Venous Pulse in the Clinical Examination of the Heart. II. The Venous Pulse. (Cronin RFP. The Venous Pressure and Venous Pulse in the Clinical Examination of the Heart. I. The Venous Pressure. Can Med Assoc J. 1958 March 15; 78(6): 406–412) |
| TROPONIN I AND TROPONIN T IN MYOCARDIAL INFARCTION DIAGNOSIS AND RISK ASSESSMENT. (Katherine Soreng, Ph.D. Bayer HealthCare LLC, Diagnostics Division) |
| Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy. (Felker GM, Thompson RE, Hare JM et al. N Engl J Med 2000; 342:1077-1084) |
| Universal Definition of Myocardial Infarction. (Thygesen K; Alpert JS, White HD et al . Circulation 2007;116;2634-2653) |
| Use of a Prognostic Treadmill Score in Identifying Diagnostic Coronary Disease Subgroups. (Leslee JS, Peterson ED, Shaw LK et al. Circulation 1998;98:1622-1630) |
| Validation of Clinical Classification Schemes for Predicting Stroke. (Gage BF,Waterman AD,Shannon W et al. JAMA. 2001;285:2864-2870.) |
| Why is the measurement of jugular venous pressure discredited? . (van't Laar A. The Netherlands Journal of Medicine, Volume 61, Number 7, July 2003 , pp. 268-272) |
